Genetic and epigenetic bases of the relationship between reduced OCT1 expression and poor response to sorafenib in hepatocellular carcinoma and cholangiocarcinoma

被引:1
|
作者
Al-Abdulla, R. [1 ]
Lozano, E. [2 ]
Macias, R. I. [2 ]
O'Rourke, C. J. [3 ]
Perez, M. J. [2 ]
Serrano, M. A. [2 ]
Romero, M. R. [2 ]
Monte, M. J. [2 ]
Herraez, E. [2 ]
Briz, O. [2 ]
Banales, J. M. [4 ]
Bujanda, L. [4 ]
Geier, A. [5 ]
Andersen, J. B. [3 ]
Marin, J. J. [2 ]
机构
[1] Univ Salamanca, IBSAL, Expt Hepatol & Drug Targeting HEVEFARM, Salamanca, Spain
[2] Univ Salamanca, Expt Hepatol & Drug Targeting HEVEFARM, IBSAL, CIBERehd, Salamanca, Spain
[3] Univ Copenhagen, Biotech Res & Innovat Ctr, Dept Hlth & Human Sci, Copenhagen, Denmark
[4] Univ Basque Country, San Sebastian Univ Hosp, Biodonostia Biomed Res Inst, Dept Hepatol & Gastroenterol, San Sebastian, Spain
[5] Wurzburg Univ Hosp, Dept Med 2, Div Hepatol, Wurzburg, Germany
关键词
D O I
10.1016/S0168-8278(17)31309-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-115
引用
收藏
页码:S462 / S463
页数:2
相关论文
共 44 条
  • [21] DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
    Ssu-Chuan Lai
    Yu-Ting Su
    Ching-Chi Chi
    Yung-Che Kuo
    Kam-Fai Lee
    Yu-Chih Wu
    Pei-Chi Lan
    Muh-Hwa Yang
    Te-Sheng Chang
    Yen-Hua Huang
    Journal of Experimental & Clinical Cancer Research, 38
  • [22] Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1
    Nishida, Naoshi
    Sakai, Kazuko
    Morita, Masahiro
    Aoki, Tomoko
    Takita, Masahiro
    Hagiwara, Satoru
    Komeda, Yoriaki
    Takenaka, Mamoru
    Minami, Yasunori
    Ida, Hiroshi
    Ueshima, Kazuomi
    Nishio, Kazuto
    Kudo, Masatoshi
    LIVER CANCER, 2020, 9 (04) : 426 - 439
  • [23] Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
    Ssu-Chuan Lai
    Yu-Ting Su
    Ching-Chi Chi
    Yung-Che Kuo
    Kam-Fai Lee
    Yu-Chih Wu
    Pei-Chi Lan
    Muh-Hwa Yang
    Te-Sheng Chang
    Yen-Hua Huang
    Journal of Experimental & Clinical Cancer Research, 39
  • [24] High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma
    Jianjun Xu
    Zhe Su
    Xiang Cheng
    Shaobo Hu
    Wenjie Wang
    Tianhao Zou
    Xing Zhou
    Zifang Song
    Yun Xia
    Yang Gao
    Qichang Zheng
    Cancer Cell International, 22
  • [25] High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma
    Xu, Jianjun
    Su, Zhe
    Cheng, Xiang
    Hu, Shaobo
    Wang, Wenjie
    Zou, Tianhao
    Zhou, Xing
    Song, Zifang
    Xia, Yun
    Gao, Yang
    Zheng, Qichang
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [26] Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma
    Abdou, Asmaa Gaber
    Abd El-Wahed, Moshira Mohammed
    Kandil, Mona Abd-Elhalim
    Samaka, Rehab Monir
    Elkady, Noha
    APMIS, 2013, 121 (10) : 982 - 996
  • [27] Associations between high levels of Notch1 expression and high invasion and poor overall survival in hepatocellular carcinoma
    Zhou, Liang
    Zhang, Ning
    Li, Qing-jun
    Sun, Wei
    Zhang, Yong
    Wang, De-sheng
    Dou, Ke-feng
    TUMOR BIOLOGY, 2013, 34 (01) : 543 - 553
  • [28] The Relationship Between Single-Nucleotide Polymorphisms, the Expression of DNA Damage Response Genes, and Hepatocellular Carcinoma in a Polish Population
    Krupa, Renata
    Czarny, Piotr
    Wigner, Paulina
    Wozny, Joanna
    Jablkowski, Maciej
    Kordek, Radzislaw
    Szemraj, Janusz
    Sliwinski, Tomasz
    DNA AND CELL BIOLOGY, 2017, 36 (08) : 693 - 708
  • [29] Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma
    Xiang Zhou
    Yongquan Hu
    Hong Sun
    Ruohua Chen
    Gang Huang
    Jianjun Liu
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3107 - 3115
  • [30] Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma
    Zhou, Xiang
    Hu, Yongquan
    Sun, Hong
    Chen, Ruohua
    Huang, Gang
    Liu, Jianjun
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (10) : 3107 - 3115